Skip to Content
Merck
All Photos(1)

Key Documents

Safety Information

C1374

Sigma-Aldrich

CDK6/CyclinD1, active, His/GST tagged human

PRECISIO® Kinase, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution

Synonym(s):

CCND1, Cell division protein kinase 6, BCL1, CDK6, D11S287E, MGC59692, PLSTIRE, PRAD1, U21B31

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
12352200
NACRES:
NA.32

recombinant

expressed in baculovirus infected Sf9 cells

Quality Level

product line

PRECISIO® Kinase

Assay

≥70% (SDS-PAGE)

form

buffered aqueous glycerol solution

specific activity

7.9-10.7 nmol/min·mg

mol wt

CDK6 subunit ~40 kDa
cyclin D1 ~61 kDa

technique(s)

activity assay: suitable

solubility

soluble
water: soluble

UniProt accession no.

shipped in

dry ice

storage temp.

−70°C

Gene Information

General description

Research area: APOPTOSIS

This recombinant product was expressed by baculovirus in Sf9 insect cells using an N-terminal His-tag on CDK6, and a GST-tag on Cyclin D1.

Application

CDK6/CyclinD1, active, His/GST tagged human has been used in: In vitro CDK6 activity assay to evaluate the effects of small-molecule inhibitors for therapeutic haematopoietic stem cells (HSC) expansion.

Biochem/physiol Actions

Cyclin Dependent Kinases6 (CDK6) is a member of the cyclin-dependent family of protein kinases that are important regulators of cell cycle progression. CDK6 activity is regulated by the D-type cyclins and members of the INK4 family of CDK inhibitors. CDK6 kinase activity is detected during the mid-G1 phase of the cell cycle. It plays a crucial role in phosphorylating and regulating the activity of the retinoblastoma (RB), a tumor suppressor protein. Moreover, CDK6 has active involvement during transcription in hematopoietic stem cells (HSC) and tumor cells. Although CDK6 and CDK4 can both phosphorylate multiple residues in the Rb protein, they do so with different residue selectivity in vitro; CDK6 phosphorylates Thr821 while CDK4 phosphorylates Thr826 on Rb protein. The activation of cyclin D1-dependent kinase activity is found to be necessary to trigger the process of apoptosis.

Physical form

Supplied in 50 mM Sodium Phosphate, pH 7.0, with 300 mM NaCl, 150 mM imidazole, 0.1 mM PMSF, 0.2 mM DTT, and 25% glycerol.

Legal Information

PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

10 - Combustible liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

Cartagena Act

Cartagena Act Listed

JAN Code

C1374-BULK:
C1374-VAR:
C1374-10UG-PW:
C1374-10UG:


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tohru Takaki et al.
Journal of biochemistry, 137(3), 381-386 (2005-04-06)
D-type cyclin-dependent kinases (Cdk4 and Cdk6) regulate the G1 to S phase progression of the mammalian cell cycle. It has been suggested that Cdk4 and Cdk6 may have distinct functions in vivo, even though they are indistinguishable biochemically. Here we
M Meyerson et al.
Molecular and cellular biology, 14(3), 2077-2086 (1994-03-01)
A family of vertebrate cdc2-related kinases has been identified, and these kinases are candidates for roles in cell cycle regulation. Here, we show that the human PLSTIRE gene product is a novel cyclin-dependent kinase, cdk6. The cdk6 kinase is associated
Haizhen Wang et al.
Nature, 546(7658), 426-430 (2017-06-14)
D-type cyclins (D1, D2 and D3) and their associated cyclin-dependent kinases (CDK4 and CDK6) are components of the core cell cycle machinery that drives cell proliferation. Inhibitors of CDK4 and CDK6 are currently being tested in clinical trials for patients
Yingdai Gao et al.
Nature communications, 6, 6328-6328 (2015-02-19)
Among cyclin-dependent kinase inhibitors that control the G1 phase in cell cycle, only p18 and p27 can negatively regulate haematopoietic stem cell (HSC) self-renewal. In this manuscript, we demonstrate that p18 protein is a more potent inhibitor of HSC self-renewal

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service